Duchenne News Tags: Upsher-Smith

December 15, 2025
On December 1, 2025, Upsher-Smith Laboratories, LLC (Upsher-Smith) announced the launch of KYMBEEâ„¢ (deflazacort) Tablets, indicated for the treatment of Duchenne muscular dystrophy in patients 5 years of age and...

Experience the magic this summer!

How is the rare disease community accomplishing goals?

Tune in on February 29 to hear from our panel and moderators on how they are accomplishing goals and living life to the fullest!

Your gift helps Jett Foundation provide programming and opportunities, such as Camp Promise, to many families impacted by Duchenne muscular dystrophy each year.

Accessible Vehicle Fund Applications Open